http://dermatologytimes.modernmedicine.com/dermatologytimes The Leading Newsmagazine for Dermatologists. Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research. 2012-02-11T21:00:34Z http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Gatekeeper-identified-for-skin-inflammation/ArticleStandard/Article/detail/757902?ref=25 A new study has identified key signals that regulate protective and sometimes pathological skin inflammation, and also identifies a “gatekeeper” that, when lost, can cause inflammatory skin disease in the absence of injury or infection. 2012-02-08T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/062012/757902null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Business-booms-for-tattoo-removers-analysts-say/ArticleStandard/Article/detail/757901?ref=25 The tattoo boom of recent years has spawned an additional growth industry. The ranks of tattoo removal practitioners have increased substantially over the past five years, with revenue rising at an average annual rate of about 21 percent to $65.6 million in 2012, market analysis firm IBISWorld reports. 2012-02-08T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/062012/757901null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/FDA-clears-Cynosures-cellulite-treating-laser/ArticleStandard/Article/detail/757884?ref=25 The Food and Drug Administration has cleared Cynosure’s Cellulaze Workstation, a cellulite treatment device, for commercial distribution, the company announced. 2012-02-08T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/062012/757884null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Derm-residents-cheating-ABD-responds-to-CNN-story/ArticleStandard/Article/detail/757903?ref=25 The American Board of Dermatology has warned residents that the practice of using so-called “airplane notes” to cheat on certification exams is illegal, the board’s executive director says. 2012-02-08T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/062012/757903null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lymphoma-diagnosis-may-be-missed-without-careful-e/ArticleStandard/Article/detail/757577?ref=25 The cutaneous symptoms of lymphoma and atopic dermatitis (AD) can mimic one another, particularly when AD is severe. An accurate evaluation and assessment of the presenting clinical symptoms is crucial in avoiding a potential misdiagnosis of either disease. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757577null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Growing-array-of-filler-options-changes-dermatolog/ArticleStandard/Article/detail/757563?ref=25 Beginning in 2003, with approval of human collagen and in the following years the introduction of products containing hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid and more, it's no surprise that fillers have taken on an ever-increasing role in aesthetic dermatology. On Call wondered whether dermatologists' treatment techniques have changed as a result of the growing array of product options, and if so, how. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757563null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lipolysis-innovations-target-demand-for-noninvasiv/ArticleStandard/Article/detail/757564?ref=25 Body contouring is the next aesthetic frontier, and thanks to advances in noninvasive lipolysis, the future is very bright, says Mark S. Nestor, M.D., Ph.D. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757564null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-sunscreen-labeling-represents-step-forward-in-/ArticleStandard/Article/detail/757570?ref=25 Implementation of the final regulations from the Food and Drug Administration for sunscreen testing and labeling should enable consumer selection of effective sunscreen products. More work is still needed, however, to better educate the public about the damaging effects of UV exposure and to motivate appropriate sunscreen use, says Vincent A. DeLeo, M.D. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757570null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/HIPAA-privacy-rules-become-complex-in-dementia-cas/ArticleStandard/Article/detail/757557?ref=25 Dr. Doe has practiced dermatology for more than three decades and has seen many of his patients become quite elderly. He is saddened by the senility of some of these patients, and he is worried about their ability to consent to various office-provided procedures. One of his patients with dementia has a brother who holds a power of attorney that becomes effective when the described patient is no longer able to make decisions for himself. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757557null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Short-pulse-applications-of-1064-nm-laser-devices-/ArticleStandard/Article/detail/757556?ref=25 Neodymium is a crystal that is used as a lasing medium for some solid-state lasers. The 1,064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser emits monochromatic light in the near-infrared spectrum. Near-infrared lasers include other devices emitting wavelengths between 750 nm and 1,400 nm. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757556null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Pine-bark-extract-improves-skin-aging-signs/ArticleStandard/Article/detail/757291?ref=25 Clinical trial results suggest that natural supplement Pycnogenol (Horphag Research), an antioxidant plant extract from the bark of the French maritime pine tree, improves skin hydration and elasticity in women. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757291null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Physician-extenders-help-to-combat-shortage-of-pra/ArticleStandard/Article/detail/757567?ref=25 Dermatologists are increasingly turning to "extenders" — physician assistants and nurse practitioners — to combat a shortage of doctors in the specialty. These mid-level providers and the physicians who hire them say teamwork and training are among the keys for successful collaborations. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757567null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Infants-with-severe-atopic-dermatitis-require-team/ArticleStandard/Article/detail/757560?ref=25 The unique needs of infants with severe atopic dermatitis require special attention. As such, says Mary Wu Chang, M.D., associate clinical professor of dermatology and pediatrics, University of Connecticut School of Medicine, "This is not something you can handle in a 15-minute visit." 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757560null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Off-label-treatment-with-biologics-effective-for-t/ArticleStandard/Article/detail/757578?ref=25 Biologic drugs have proven to be of benefit for diseases where there is no indicated treatment, such as for immunobullous diseases. "Pemphigus vulgaris with rituximab (Rituxan, Genentech) has been a major advance, although this is not a formally approved indication for the drug," says Alan Menter, M.D., chief, dermatology, and chairman, residency program, Baylor University Medical Center, Dallas. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757578null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/No-infection-environmental-cause-found-for-Morgell/ArticleStandard/Article/detail/757290?ref=25 The Centers for Disease Control and Prevention has released a study that finds no evidence linking Morgellons disease to an infection or environmental cause. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757290null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Favorable-risk-profile-for-botulinum-toxin-A-suppo/ArticleStandard/Article/detail/757575?ref=25 Even though botulinum toxin type A is one of the most potent neurotoxins known, its injection into muscles for the reduction of hyperfunctional lines is one of the safest procedures being performed in cosmetic dermatology. And the favorable risk-to-benefit profile of the toxin is fueling its use in an expanding number of off-label applications, says Thomas E. Rohrer, M.D. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757575null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hair-restoration-research-explores-multiple-uses-f/ArticleStandard/Article/detail/757565?ref=25 A naturally secreted, embryonic-like human cell conditioned media (hCCM) used as a follicle holding solution (FHS) holds promise for improving outcomes of hair transplantation surgery, according to clinical trial findings reported by Neil S. Sadick, M.D., at the 2011 annual meeting of the American Society for Dermatologic Surgery. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757565null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/FDA-approves-vismodegib-for-basal-cell-cancers/ArticleStandard/Article/detail/757288?ref=25 The Food and Drug Administration has approved the groundbreaking, first-in-class drug Erivedge (vismodegib, Genentech) to treat adult patients with advanced and metastatic basal cell cancers. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757288null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Studying-fine-art-enhances-clinical-observational-/ArticleStandard/Article/detail/757571?ref=25 Analyzing 18th and 19th century (Victorian-era) paintings can help dermatologists think beyond their established habits and preconceptions in the search for visual and other diagnostic clues, says Irwin Braverman, M.D., professor of dermatology, Yale School of Medicine. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757571null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inclusionexclusion-criteria-for-drug-studies-can-b/ArticleStandard/Article/detail/757568?ref=25 Drugs, by definition, are not safe. Exactly how safe a drug must be is a topic of much controversy. However, it is hard to determine the safety of many drugs because the inclusion/exclusion criteria for study protocols requires that the drug be studied in persons who are not pregnant or lactating and who are usually above the age of 12, and in those who have normal test results and normal physical exams. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757568null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Topical-PDT-highly-effective-for-primary-axillary-/ArticleStandard/Article/detail/757555?ref=25 Photodynamic therapy (PDT) using a topically applied liposomal eosin hydrogel is an effective treatment for primary axillary hyperhidrosis, according to a study reported at the 31st annual meeting of the American Society for Laser Medicine and Surgery. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757555null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Harvard-derm-delves-into-origin-of-pruritus-adding/ArticleStandard/Article/detail/757561?ref=25 Born into an accomplished dermatology family, Ethan Lerner, M.D., has had to ask himself if he had any choice but to join the specialty. His father, the late Aaron B. Lerner, M.D., former professor and chairman of the Yale University dermatology department, discovered melatonin and developed transplantation therapy for vitiligo. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757561null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/FDA-OKs-ingenol-mebutate-for-AK-treatment/ArticleStandard/Article/detail/757289?ref=25 The Food and Drug Administration has approved Picato gel (ingenol mebutate, Leo Pharma) as a treatment for actinic keratoses on the face, scalp, trunk and extremities. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757289null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Ban-baseball-caps-Aussie-cancer-council-urges/ArticleStandard/Article/detail/757292?ref=25 The Cancer Council of New South Wales says baseball caps should be banned from schools because they place children at an unacceptable risk of developing skin cancers later in life, the Sydney Morning Herald reports. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757292null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Federal-governments-eRx-incentive-program-criteria/ArticleStandard/Article/detail/757573?ref=25 In 2009, the federal government launched its Electronic Prescribing (eRx) Incentive Program. Although this program (which was authorized in the Medicare Improvements for Patients and Providers Act of 2008/MIPPA) is now three years old, physicians remain confused about the details. Fortunately, the eRx Incentive Program is straightforward. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757573null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Physicians-continue-to-ponder-best-decision-regard/ArticleStandard/Article/detail/757576?ref=25 Politicians on Capitol Hill once again have dermatologists — and all physicians who serve Medicare patients — wondering what in the name of common sense they are going to do. Just before Christmas, Congress delayed a 27.4 percent Medicare fee cut from its original Jan. 1 implementation date. The cut is now scheduled, barring any further congressional action, to take effect Feb. 29. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757576null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Actinic-keratosis-NMSC-treatments-benefit-from-inn/ArticleStandard/Article/detail/757559?ref=25 Future management of actinic keratosis (AK) and nonmelanoma skin cancer (NMSC) will involve creative uses of conventional therapies, particularly in multimodal regimens, and it will be expanded by recent advances in chemotherapy, according to Theodore Rosen, M.D., who spoke at the 30th annual Fall Clinical Dermatology Conference. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757559null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/CME-advanced-training-available-for-mid-level-prac/ArticleStandard/Article/detail/757856?ref=25 National report — Many mid-level providers get their dermatology training on the job, but continuing education and advanced training opportunities also are available. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/062012/757856null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Biologic-agents-relieve-chronic-skin-conditions-wh/ArticleStandard/Article/detail/757574?ref=25 Biologic therapies can help patients with dermatologic conditions, providing anti-inflammatory benefits without significant effects on other organ systems, says Steven R. Feldman, M.D., Ph.D., professor of dermatology, pathology and public health sciences, Wake Forest Baptist Medical Center, Winston-Salem, N.C. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757574null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Roles-of-p53-gene-in-photodamage-diabetes-in-intri/ArticleStandard/Article/detail/757562?ref=25 The p53 gene is very important in dermatology for the prevention of skin cancer. P53 is the gene that is activated when viable epidermal skin cells are damaged by UV radiation. UV radiation strikes the skin and is first transformed to heat by an organic sunscreen and possibly reflected by an inorganic sunscreen. If the sunscreen fails to diffuse all of the damaging UV radiation, keratinocytes function to reflect and scatter the radiation. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757562null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stopping-necroptosis-may-prevent-skin-inflammation/ArticleStandard/Article/detail/757572?ref=25 Stopping of a type of regulated cell death called necroptosis in keratinocytes is critical for the prevention of skin inflammation, according to new research from Germany. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757572null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Clinicians-concerned-about-safety-efficacy-of-bios/ArticleStandard/Article/detail/757558?ref=25 Biosimilars are designed to mimic biologic agents, but they are not precise duplicates of these drugs. Biosimilars may prove useful for treating skin conditions such as psoriasis, but clinicians are waiting for guidance on the drugs from the Food and Drug Administration, which was still pending at press time. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757558null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Biologics-potential-for-side-effects-calls-for-tho/ArticleStandard/Article/detail/757566?ref=25 Biologics may provide excellent relief from psoriasis, but that relief comes with the potential for serious side effects, mainly associated with an altered immune system. As a result, Kevin Cooper, M.D., emphasizes the importance of making sure patients are physically and mentally prepared for undergoing biologic therapies. 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757566null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Safety-profile-of-biologics-evolves-but-long-term-/ArticleStandard/Article/detail/757569?ref=25 New safety profile data continues to emerge on biologics used in psoriasis. Among the findings: Today's biologics do not appear to increase serious infection risk; the drugs' short-term cancer risk profile is promising; but concerns remain about long-term cancer risk with all biologics and cardiovascular risk with interleukin-12/23, ustekinumab (Stelara, Janssen Biotech). 2012-02-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052012/757569null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Copper-socks-helped-Chilean-miners-foot-fungus/ArticleStandard/Article/detail/756879?ref=25 The August 2010 Chilean mine collapse that trapped 33 miners underground for 69 days made more news last week for a less dramatic but, for some, still significant reason: a potentially improved treatment for fungal foot infections. 2012-01-25T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/042012/756879null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Melanoma-rates-drop-for-most-educated-whites/ArticleStandard/Article/detail/756881?ref=25 While the overall death rate from melanoma has been declining among whites in recent years, the decline is only significant among the most highly educated sector of that population. 2012-01-25T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/042012/756881null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Teledermatology-improves-outcomes-study-shows/ArticleStandard/Article/detail/756878?ref=25 Use of interactive teledermatology consultations leads to improved clinical outcomes for patients, according to a new study from the University of California, Davis, School of Medicine. 2012-01-25T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/042012/756878null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Acne-risk-higher-for-overweight-teen-girls/ArticleStandard/Article/detail/756880?ref=25 Teenage girls who are obese or overweight are significantly more likely to develop acne than their normal-weight peers, a new Norwegian survey suggests. 2012-01-25T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/042012/756880null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Device-detects-melanoma-before-tumors-develop/ArticleStandard/Article/detail/756463?ref=25 University of Missouri researchers are close to seeking regulatory approval for a new photoacoustic device they say can detect melanoma before tumors develop. 2012-01-18T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/032012/756463null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Suneva-tests-Artefill-for-acne-scar-treatment/ArticleStandard/Article/detail/756464?ref=25 Suneva Medical has launched a multicenter phase 3 study to investigate the efficacy of the dermal filler Artefill (polymethylmethacrylate) for treatment of acne scars. 2012-01-18T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/032012/756464null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Fruit-vegetable-concentrates-improve-skin-health/ArticleStandard/Article/detail/756466?ref=25 Results of a new study suggest that regular intake of fruit and vegetable concentrates can improve objective markers of skin health. 2012-01-18T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/032012/756466null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/LEO-Virobay-to-develop-oral-psoriasis-drug/ArticleStandard/Article/detail/756465?ref=25 Denmark-based LEO Pharma has signed an in-licensing deal with the Menlo Park biotech company Virobay to develop an oral treatment for psoriasis. 2012-01-18T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/032012/756465null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/New-study-Botox-affects-distant-muscles-too/ArticleStandard/Article/detail/755493?ref=25 Results of a new study suggest that Botox (onabotulinumtoxinA, Allergan) has previously unsuspected and long-lasting systemic effects on muscles other than the ones into which it’s injected. 2012-01-11T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/022012/755493null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Consumer-groups-sue-FDA-over-nanotech-regulation/ArticleStandard/Article/detail/755494?ref=25 A coalition of six consumer advocacy groups is suing the Food and Drug Administration over regulation of nanotechnology, Minnesota Public Radio reports. 2012-01-11T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/022012/755494null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/MRSA-sanitizers-largely-a-myth-FDA-warns/ArticleStandard/Article/detail/755496?ref=25 The Food and Drug Administration is warning consumers that several companies are making unproven claims that their products will prevent methicillin-resistant Staphylococcus aureus infections, the McClatchy-Tribune News Service reports. 2012-01-11T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/022012/755496null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/American-Board-of-Dermatology-elects-Dr-Lim-presid/ArticleStandard/Article/detail/755497?ref=25 Henry W. Lim, M.D., chairman of the department of dermatology at Henry Ford Hospital, is the new president of the American Board of Dermatology. 2012-01-11T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/022012/755497null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Patient-injured-in-wart-remover-drug-mix-up/ArticleStandard/Article/detail/755495?ref=25 The Food and Drug Administration has issued a warning to pharmacists and healthcare professionals to beware of confusing Durasal, a wart remedy containing salicylic acid, with the prescription eye drops Durezol (difluprednate ophthalmic emulsion, Alcon). 2012-01-11T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/022012/755495null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Study-Maggots-clean-wounds-faster-than-surgeons/ArticleStandard/Article/detail/753922?ref=25 Results of a French study suggest that maggots can debride wounds more quickly than can surgeons, and that using maggots may be useful in selected cases, Foxnews.com reports. 2012-01-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753922null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Memory-cell-may-suppress-autoimmunity/ArticleStandard/Article/detail/753923?ref=25 The immune system includes a type of cell that can be activated by tissues within the body to “remind” the system not to attack the body’s own molecules, cells and organs, according to researchers at the University of California, San Francisco. 2012-01-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753923null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Bottled-tan-users-reduce-risky-practices/ArticleStandard/Article/detail/753924?ref=25 A new study suggests that women who get their tan from a bottle may spend less time sunbathing or using tanning beds — and thus may be at lower risk of acquiring skin cancer from exposure to ultraviolet rays, USA Today reports. 2012-01-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753924null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/New-hydrogel-regenerates-scar-free-tissue/ArticleStandard/Article/detail/753905?ref=25 Johns Hopkins University researchers have developed a wound-healing method using a gel that appears to regenerate healthy, scar-free tissue. 2012-01-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753905null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Afternoon-sun-exposure-carries-greater-risk-of-ski/ArticleStandard/Article/detail/754215?ref=25 The risk of developing skin cancer from sun exposure in the afternoon is significantly greater than from exposure in the morning, a new study shows. What makes the difference? It's not the exposure, per se, but the cellular repair mechanism for UV damage to DNA, which is circadian in nature and at its peak efficiency early in the day. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754215null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Rising-woundcare-costs-warrant-personalized-approa/ArticleStandard/Article/detail/754214?ref=25 Skin ulcers and wounds are the most expensive diseases of the skin in the United States, feeding a multibillion-dollar industry of woundcare systems. But which therapies are best? Are simpler and cheaper alternatives an option? And which alternatives work best with standard of care? 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754214null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dermatologist-physician-husband-create-software-fo/ArticleStandard/Article/detail/754205?ref=25 An Ohio dermatologist and her husband are developing a software program that will allow dermatologists to incorporate homeopathy as a treatment option for patients who desire an alternative approach. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754205null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Physicians-outline-homeopathic-approach-for-treati/ArticleStandard/Article/detail/753933?ref=25 At Trillium Creek Dermatology in Medina, Ohio, we have begun developing a homeopathic dermatologic treatment option for patients with acute and chronic skin complaints. This initial article defines where the theoretical paradigm of homeopathic medicine differs from allopathic medicine. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753933null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dermatologists-delay-retirement-reduce-staffs-as-t/ArticleStandard/Article/detail/754202?ref=25 On Call wondered how dermatologists have fared through the financial crisis and whether their retirement plans have been impacted by the uncertain market and economy. Have they been making adjustments in their practices to better prepare for retirement down the road? 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754202null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Using-post-procedure-photos-for-ads-can-constitute/ArticleStandard/Article/detail/754206?ref=25 The use of patient photography, videotaping, digital imaging and other visual recordings during cosmetic filler treatment is common. Although cosmetic patient photographic documentation is common, liability issues need to be considered and federal regulations observed. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754206null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/A-peek-into-tomorrows-insurance-medical-paradigms-/ArticleStandard/Article/detail/754203?ref=25 A few months ago, I received a certified letter from one of the Medicare Advantage insurance carriers with which we are contracted. The letter stated that our services were no longer needed. They had no complaints about the services we were delivering; rather, they had made the decision to hire a nurse practitioner to care for the dermatologic needs of their enrollees. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754203null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Alexandrite-laser-a-versatile-tool-for-variety-of-/ArticleStandard/Article/detail/754199?ref=25 Like the stone that sits at its core, the alexandrite laser is a versatile instrument that has many applications in dermatology. Jewelers have used the gemstone for more than a century, but it was not until the 1990s that it was used for medical conditions. In 1997, the Food and Drug Administration approved the 755 nm alexandrite laser for hair removal. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754199null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Naturopathic-therapies-provide-powerful-adjunct-in/ArticleStandard/Article/detail/753862?ref=25 Patients undergoing conventional treatment for skin cancer can benefit from adjunctive strategies implemented by naturopathic physicians, says Katherine Anderson, N.D., F.A.B.N.O., director of naturopathic medicine, Cancer Treatment Centers of America, Southwestern Regional Medical Center, Tulsa, Okla. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753862null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Medicare-reimbursement-controversy-expected-to-esc/ArticleStandard/Article/detail/754200?ref=25 The battle over Medicare spending and how much dermatologists and other physicians are paid for treating Medicare patients is expected to escalate in 2012, with major policy decisions to be faced by Congress in the heat of congressional and presidential election campaigns. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754200null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Scrutinizing-safety-of-sunscreens-nail-polish-othe/ArticleStandard/Article/detail/754210?ref=25 It may surprise many consumers that the preservatives used in sunscreens are more problematic than the filters themselves. Most preservatives are antimicrobial and as such possess some intrinsic toxicities. All products, including sunscreens, possess some risk. To this end, sunscreens should not be eaten. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754210null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dietary-supplements-selected-with-care-can-improve/ArticleStandard/Article/detail/754197?ref=25 Dietary supplements have garnered a variety of coverage in the news lately, some positive and some otherwise. But according to one dermatologist, the media excitement over supplements is a big reason why dermatologists need to learn about naturopathic therapies so they can give accurate advice to their patients. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754197null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IBD-depression-risks-with-isotretinoin-very-small-/ArticleStandard/Article/detail/754198?ref=25 Although it's tough to accurately assess the associations between isotretinoin use and inflammatory bowel disease (IBD), bone abnormalities or depression, research to date shows that these risks are very small. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754198null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Dermatologists-other-specialists-team-up-in-effort/ArticleStandard/Article/detail/751814?ref=25 The University Hospitals Interdisciplinary Eczema Clinic integrates the many aspects of care to optimally manage a multifactorial, chronic disease: eczema. Its mission is to better address the complex needs of eczema patients and, ultimately, provide a model of care for chronic dermatologic diseases. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/502011/751814null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Acupunctures-effects-beneficial-for-certain-dermat/ArticleStandard/Article/detail/754208?ref=25 Several common dermatologic conditions — including acne and psoriasis — can be effectively treated with acupuncture and Chinese herbal medicine, according to Ryan Lombardo, D.A.O.M., L.Ac., A.B.A.A.H.P., of Evanston, Ill., doctor of acupuncture and Oriental medicine. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754208null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Much-can-be-done-to-manage-impact-of-missed-patien/ArticleStandard/Article/detail/754201?ref=25 Gaps in the daily schedule waste your time and money. More often than not, these unintended gaps are the result of patients who cancel at the last minute or just don't show up. Because you bear all of the overhead costs for the staff, facility and other costs related to each appointment time slot, a "no-show" is a direct hit on your dermatology practice's bottom line. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754201null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Chronic-shortage-of-dermatologists-leaves-some-are/ArticleStandard/Article/detail/754204?ref=25 Robert Brodell, M.D., has been searching for an associate for three years — to no avail. The northeast Ohio dermatologist says he works about 50 hours a week, but still has more patients than he can comfortably handle. People with non-emergencies typically wait six to eight weeks for an appointment. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754204null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Epidemiology-data-for-melanoma-serves-up-good-bad-/ArticleStandard/Article/detail/754209?ref=25 Although dermatologists may be disheartened by the latest melanoma epidemiology data showing continued rises in incidence and the annual number of melanoma-related deaths, recent advances in prevention, diagnosis and treatment should raise hope for the future, according to Darrell S. Rigel, M.D., who spoke at the 30th Annual Fall Clinical Dermatology Conference. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754209null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cleveland-dermatologist-uses-power-of-teamwork-to-/ArticleStandard/Article/detail/754211?ref=25 Susan T. Nedorost, M.D., is on a mission to change what she says is a problem for patients plagued by eczema. "Dermatitis has been the poor stepsister to psoriasis," Dr. Nedorost says. "Now, I think it's going to get the attention that it deserves because the burden of disease is just as great as psoriasis." 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754211null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Fibroblast-injection-improves-depressed-acne-scars/ArticleStandard/Article/detail/754196?ref=25 Injection of autologous cultured fibroblasts (azficel-T; Laviv, Fibrocell Science) is safe and effective for improving the appearance of distensible, depressed acne scars, according to the results of a prospective, double-blind, placebo-controlled clinical trial reported by Girish "Gilly" Munavalli, M.D., at the 2011 annual meeting of the American Society for Dermatologic Surgery. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754196null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Photodynamic-therapy-increasingly-valuable-with-on/ArticleStandard/Article/detail/754207?ref=25 Accumulating experience with photodynamic therapy (PDT) has led to an expanding list of applications and new protocols that together have made PDT an increasingly valuable tool in the management of actinic keratosis (AK) and nonmelanoma skin cancer (NMSC). 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754207null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Reflectance-confocal-microscopy-lets-physicians-vi/ArticleStandard/Article/detail/754213?ref=25 Reflectance confocal microscopy (RCM) is a relatively new technique that can help clinicians more accurately evaluate both melanocytic and nonmelanocytic skin lesions. It may even negate the need for biopsy in certain instances, an Austrian dermatologist says. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754213null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Herbal-preparations-can-resolve-skin-conditions/ArticleStandard/Article/detail/753859?ref=25 Determining the underlying cause of a skin condition is the approach in naturopathic medicine, and making changes to avoid triggers can often lead to the resolution of conditions such as atopic dermatitis or psoriasis, two naturopathic doctors say. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753859null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Nonphysician-providers-highly-useful-in-busy-derma/ArticleStandard/Article/detail/754212?ref=25 A nonphysician provider can be an invaluable resource in a busy dermatologic practice. Given the proper training and the appropriate time to gain the experience needed, nonphysician providers can help to significantly shorten the wait time of patients, which can lead to an increased volume of clientele while decreasing the workload of the dermatologist, says one physician. 2012-01-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/532011/754212null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Novel-drug-effective-against-MRSA-caused-impetigo/ArticleStandard/Article/detail/753835?ref=25 NovaBay Pharmaceuticals says early results of a phase 2 clinical study show that its AgaDerm NVC-422 gel is effective in treating impetigo caused by methicillin-resistant Staphyloccus aureus. 2011-12-28T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753835null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Smoking-linked-to-nonmelanoma-skin-cancers/ArticleStandard/Article/detail/753833?ref=25 Results of a new study offer yet another reason not to smoke. A research ream led by Dana E. Rollison, Ph.D., of the Moffitt Cancer Center in Tampa, has determined that nonmelanoma skin cancer (NMSC) patients are twice as likely to have ever smoked as those with no past or present history of skin cancer. 2011-12-28T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753833null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Study-proposes-method-to-rank-retouched-ad-photos/ArticleStandard/Article/detail/753873?ref=25 Dartmouth College researchers are seeking ways to provide consumers with more accurate images of models and celebrities than the images seen in highly retouched and computer-altered advertising photos. 2011-12-28T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753873null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Outlook-Derm-revenues-to-rise-61-percent-in-2012/ArticleStandard/Article/detail/753832?ref=25 The coming years will be good ones for dermatologists, with industry revenues expected to rise by 6.1 percent in 2012, according to a leading market research firm. 2011-12-28T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753832null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Trend-Acne-occurs-at-younger-average-age/ArticleStandard/Article/detail/753459?ref=25 The age at which onset acne vulgaris occurs has decreased significantly, findings of a Wake Forest University study suggest. 2011-12-21T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753459null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Tanning-beds-raise-basal-cell-risk-too/ArticleStandard/Article/detail/753457?ref=25 New research suggests that the use of tanning beds, already linked to increased risk of melanoma in users, also increases the odds of developing basal cell carcinoma for young people, Reuters reports. 2011-12-21T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753457null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Study-supports-health-skin-benefits-of-plant-extra/ArticleStandard/Article/detail/753460?ref=25 Some centuries-old organic remedies — specifically white tea, witch hazel and rose — have scientifically supportable qualities that are beneficial to health and skin appearance, according to a collaborative study by researchers at London’s Kingston University and British skincare brand Neal’s Yard Remedies. 2011-12-21T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753460null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Melanoma-drug-wins-European-approval/ArticleStandard/Article/detail/753458?ref=25 European regulators have recommended approval of the targeted melanoma drug Zelboraf (vemurafenib, Roche), Reuters reports. 2011-12-21T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/522011/753458null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Grant-will-boost-teledermatology-in-California/ArticleStandard/Article/detail/752389?ref=25 Direct Dermatology, a physician-owned telemedicine company that provides dermatology services to rural and underserved patients, has received a $240,000 grant from the California HealthCare Foundation’s Health Innovation Fund. 2011-12-14T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/512011/752389null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Medicis-completes-acquisition-of-Graceway/ArticleStandard/Article/detail/752388?ref=25 Medicis has finalized its acquisition of Graceway Pharmaceuticals, of Bristol, Tenn., for $455 million, the company announced. 2011-12-14T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/512011/752388null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Lupin-gets-FDA-nod-to-sell-Solodyn-generic/ArticleStandard/Article/detail/752387?ref=25 Lupin Pharmaceuticals has received Food and Drug Administration approval to sell the generic version of the extended-release oral antibiotic Solodyn (minocycline hydrochloride, Medicis) in the United States, Reuters reports. 2011-12-14T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/512011/752387null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Chicago-derms-killer-gets-life-sentence-on-Guadelo/ArticleStandard/Article/detail/752390?ref=25 The convicted killer of a Chicago dermatologist was sentenced to life in prison on the French island of Guadeloupe, the Chicago Sun-Times reports. 2011-12-14T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/512011/752390null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Swedish-study-Peptides-kill-stubborn-emMalasseziae/ArticleStandard/Article/detail/751540?ref=25 New research suggests that certain peptides kill the yeast Malassezia sympodialis, a main culprit in triggering atopic and seborrheic eczema and dandruff, without harming healthy skin cells. 2011-12-07T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/502011/751540null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/New-stain-test-can-identify-cancerous-moles/ArticleStandard/Article/detail/751545?ref=25 Researchers at Weill Cornell Medical College have designed, developed and studied a diagnostic staining test they say can determine whether a mole is benign or cancerous relatively quickly and with minimal complexity. 2011-12-07T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/502011/751545null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/COsub2sub-laser-compares-to-surgery-for-melanoma-e/ArticleStandard/Article/detail/751546?ref=25 A new study suggests that laser ablation is a viable option to surgical excision for removing the lesion of primary lentigo maligna. 2011-12-07T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/502011/751546null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/ModernMedicine+Now/Suit-claims-Allergan-encouraged-unsafe-use-of-Boto/ArticleStandard/Article/detail/751542?ref=25 A Las Vegas plastic surgeon is suing Botox-maker Allergan, claiming the Irvine-based company sold the drug in large vials and encouraged physicians to unsafely reuse them, the Los Angeles Times reports. 2011-12-07T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/502011/751542null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Botox/Botulinum-toxin-intraoperatively-may-reduce-hypert/ArticleStandard/Article/detail/749184?ref=25 Botulinum toxin is an excellent tool to apply intraoperatively to improve the appearance of scars down the road, according to a leading dermatologic surgeon. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749184null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Moist-wound-healing-concept-gains-traction-among-p/ArticleStandard/Article/detail/749265?ref=25 Dermatologists have long embraced the concept that acute wounds heal better under occlusion. But recent acceptance of moist wound healing by plastic and cosmetic surgeons has popularized the approach among not only physicians, but also consumers, according to William H. Eaglstein, M.D., emeritus chairman, department of dermatology and cutaneous surgery, University of Miami Miller School of Medicine. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749265null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-integrated-therapies-for-wound-healing-on-the-/ArticleStandard/Article/detail/749274?ref=25 An integrated, simultaneous therapy using new treatment options and comprehensive care of the patient's underlying medical issues are leading to great advances in wound healing, according to Harold Brem, M.D., F.A.C.S., chief of the division of wound healing and regenerative medicine, Winthrop University Hospital, Mineola, N.Y. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749274null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AADA-voices-support-for-changes-to-Accountable-Car/ArticleStandard/Article/detail/749270?ref=25 Dermatologists and other healthcare providers now have to make a decision regarding whether to participate in the federal government's new Accountable Care Organization program, which was finalized in mid-October and is intended to help reduce Medicare costs while improving patient care. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749270null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Incorporate-innovative-practice-marketing-strategi/ArticleStandard/Article/detail/749259?ref=25 What works to market a dermatology practice has changed considerably in the past few years. Billboards and newspaper advertisements are still adequate, but savvy dermatologists use innovative and nontraditional approaches to marketing — and they are doing it without breaking the bank. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749259null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Make-up-for-declining-reimbursements-with-financia/ArticleStandard/Article/detail/749407?ref=25 The recent Medicare cuts in reimbursements for most physicians go from frustrating to downright scary. Layer on top of this the healthcare overhaul and it starts to feel like the federal government is determined to make it difficult for physicians to prosper. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749407null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-treatment-with-532-nm-wavelength-offers-nume/ArticleStandard/Article/detail/749263?ref=25 The next several columns will examine the wavelengths commonly used in dermatology. Understanding the properties of the wavelength and how it is produced helps give background knowledge leading to more successful clinical outcomes with these devices. This is a review of publications, and some of the treatments mentioned are considered off-label for some of the devices. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749263null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dermatologists-must-beware-of-skin-related-signs-o/ArticleStandard/Article/detail/749266?ref=25 Obsessive-compulsive disorder (OCD) makes many skin-related ailments much more than skin deep, says Thelda Kestenbaum, M.D., assistant professor, department of dermatology, University of Kansas Medical Center, Kansas City, Kan. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749266null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Reduce-lawsuit-risks-maximize-tax-liabilities-of-o/ArticleStandard/Article/detail/749393?ref=25 Real estate is a very common investment among doctors. However, very few physicians have implemented the proper legal structures to get the most out of this investment. As a result, doctors expose themselves to unnecessary lawsuit risks and pay far too much in unnecessary taxes on their real estate investments. 2011-12-01T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472011/749393null HTML